Dr. Emil Kendziorra graduated summa cum laude from the University of Göttingen and did several years of cancer research in the hopes of contributing to longevity science. After realizing how slowly life-extension research was progressing he made a pivot into entrepreneurship. He has been CEO of multiple tech and medical companies, most recently as a Founder and CEO of Medlanes (Exit to ZAVA) and onFeedback (Exit to QuestionPro). Emil has decided to dedicate the next decades of this life to advancing medical Biostasis and cryomedicine. Currently, he is the CEO of Tomorrow Bio and the President of the Board at the European Biostasis Foundation.